by Eric Ulchakere | May 20, 2020 | Uncategorized
Insurance is commonly cited by experts and addiction patients as THE BIGGEST BARRIER to obtaining treatment. In 2018 about 100,000 people in the U.S. needed drug addiction treatment, but couldn’t get the coverage they needed because of their insurance either didn’t cover it at ALL, or didn’t cover the full cost. (National Survey on Drug Use) We know that addiction isn’t a 2 month process to get clean, the need for treatment and insurance coverage needs to improve or this barrier will continue to help raise these numbers.
Collectively, we as people should answer if we are still in the day and age where addiction is seen as moral failure, instead of a medical condition?
Health insurers still resist covering treatment despite federal and state laws trying to get them to do so. Their refusal to pay means they aren’t providing any form of quality control-something they cover in almost every other sector of coverage that they provide.
The article attached shares an unfortunate story of a mother who lost her son to addiction, and the battle that she is still fighting against her insurers.
Please read and share!
https://www.vox.com/policy-and-politics/2019/11/22/20950223/drug-rehab-addiction-treatment-insurance-ed-fahy-maureen-oreilly
by Eric Ulchakere | May 20, 2020 | Students
Last week, the National Health Service Corps awarded $80 million in student loan repayments to clinicians on the front lines of the Opioid Crisis. The program aims to incentive counselors treating addiction in underserved communities, which are often those most devastated by the epidemic that is gripping our nation.
Addiction treatment centers often have difficulty retaining staff because a combination of low wages and high student loan debt from the degrees required in the field. The NHSC program aims to alleviate this burden by paying back up to $75,000 worth of loans in exchange for 3 years of service in an underserved community. Not only does this help the clinics and their staff, but most importantly it helps the patients who have built up trust with their provider.
The ‘Get Help Now Foundation’ is a charity whose mission coincides with this NHSC grant; assuring qualified addiction counselors are on the front lines. The GHNF is newly approved 501(c)(3) organization that aims to combat the Opioid Crisis by providing scholarships for clinicians pursing a master’s in addiction medicine, and certification + employment for peer-support counselors.
To learn more about the Get Help Now Foundation please visit: https://www.facebook.com/gethelpnowfoundation
by Eric Ulchakere | May 20, 2020 | Opioids
As the nation’s Opioid Crisis continues to manifest, computer scientists are turning to an unlikely source of data; Reddit. This and other online drug forums, such as Bluelight.org, provide insight to non-traditional methods of weaning oneself off opioids. The DIY methods discussed on these forums were ‘a clinical and medical blindspot’ to researchers. By bringing these self-administered treatments into the limelight, medical professionals can analyze and modify any benefits observed from these solutions.
To those suffering from Substance Use Disorder (SUD) remaining anonymous is often paramount to getting treatment, as users wish to conceal their addiction from employers, loved ones, etc. In addition, stigma surrounding drug use proves to be another barrier to seeking professional help. Online forums provide an anonymous way for those with SUD to talk with peers in a safe, judgment-free manner.
We aim to remove all barriers to care with the Apportis Opioid Solution (AOS). At the suggestion of Tracy Plouck, former Director of the Ohio Dept. of Mental Health and Addiction Services, the AOS has a built-in forum for those to share and discuss shared experiences of battling Substance Use Disorder. This provides a safe, and secure way to interact with peers, without exposing themselves to the Dark Web.
To read the full article click on the following link: https://qz.com/1735629/researchers-are-turning-to-reddit-drug-forums-to-tackle-the-opioid-crisis/
by Eric Ulchakere | May 20, 2020 | Opioids
Today Congressman Rob Portman spoke on the Senate Floor to provide some insight how Ohio has been fighting the Opioid Epidemic. There was an overwhelming progressive tone as he stressed the need to go forward and continue to build on the strides that have been made. He acknowledged how Ohio leads the country in reducing overdose deaths, which were down 22% in 2018. Senator Portman attributed this to bipartisan legislation which has allocated $4 billion of federal funding to innovative projects back home.
For example, the Rapid Response Emergency Addiction and Crisis Team (RREACT) in Columbus, OH received grant monies from the CARA Act, and has begun to have a positive impact the community. First responders noticed that they would often have to administer naloxone, the OD reversal drug, to the same user time and time again, with little to no follow-up. Herein lies the conception of the RREACT team, a group of law enforcement, EMS, social workers and treatment providers who visit the home of someone who has just overdosed. They implore the substance user to get into treatment while they are in this vulnerable state, and surprisingly have an 80% success rate.
This testimony provides an excellent example of how the Apportis Opioid Solution (AOS) can be used to fight the crisis in our state. At the suggestion of Dr. Justin Trevino, Medical Director of Ohio Mental Health & Addiction Services, AOS will be utilized in smaller communities who do not have the resources for these rapid response teams. As Senator Portman suggested, Apportis will continue to work to “close the gaps” in the Opioid Crisis in Ohio!
Here’s a link to the full video: https://www.youtube.com/watch?time_continue=477&v=MMuUANXVLIA
by Eric Ulchakere | May 20, 2020 | Medical Assisted Treatment, Opioids
Correctional facilities refuse to provide medically assisted treatment for opioid withdrawal and people are dying at alarming rates as a result.
NOTE: We at Apportis feel that this subject needs further discussion in the public sector. We have published Mr. Abraham’s article in its entirety for our subscribers. This is his work, we are just hoping to bring it to our corner of the universe. Philip Payne is not the author, but our blog tool posts the name of the person who creates the post, much apologies to Roshan Abraham, this is his fine work that we want to share.
By Roshan Abraham
When Matthew Herring was arrested in 2016 for a probation violation and sent to Dutchess County Jail* in upstate New York, he brought his medication with him. Herring, 22, had struggled with an opioid addiction for eight or nine years at that point, and had been in and out of jail since 2011, his mother Patricia Herring said. So he stashed an FDA-approved treatment drug called buprenorphine in his body to soften a painful withdrawal.
When the guards found it, however, he was thrown into solitary confinement for four days, where he suffered from withdrawal, his mother said. “They don’t have any compassion,” Herring said of her son’s treatment by correctional officers. “He’s puking his brains out, they’re laughing.”
Then, 72 days after his release from jail, Matthew died from an overdose. Herring asserts the lack of treatment on the inside played a role. “He was sick and suffering,” she said. “He was never offered medical treatment that he as human being deserved.”
People recently released from incarceration in the United States suffer alarmingly high rates of overdose deaths. A Massachusetts study found overdose deaths went up a staggering 120 percent the two weeks after release compared to the general public.
Opioid withdrawal is extremely painful and in some cases fatal; people have died in jails as a result of extreme dehydration linked to withdrawal, which causes diarrhea and vomiting. Yet only three percent of state and county correctional facilities across the U.S. carry any of the three FDA approved drugs for opioid addiction treatment: methadone, naltrexone and buprenorphine. Often when the drugs are available, it’s left up to law enforcement to decide who has access.
Overdose deaths went up a staggering 120 percent the two weeks after release.

Advocates agree the main roadblock to more states providing medically assisted treatment (MAT) to incarcerated people is stigma associated with drug use. Many correctional employees view the treatments as just another avenue for addiction, or argue it will be traded illicitly on the inside. While the National Sheriff’s Association recently released a guide to using MAT in jails, a 2016 survey of correctional officers in nine states found that officers viewed MAT as a “treatment of last resort” rather than evidence-based medicine.
There are also cost issues: sheriffs in county jails in New York said it would be hard to provide the drugs without substantial funding, though advocates have countered that the cost of not giving treatment could be higher, due to hospital visits and return jail visits. Nonetheless, the budget cuts across both public and private health care providers for incarcerated people can cut deep.
But plaintiffs who were denied treatment have been mounting successful lawsuits, strengthening the case for the treatments nationwide: an April ruling in Maine and a ruling in Massachusetts last December both held that keeping someone from medication assisted treatment violates the Americans with Disabilities Act. A bipartisan Senate bill introduced by Senators Markey and Murkowski would fund $50 million of grants for MAT in jails and prisons.
Progress is slow. Bills in the NY State Legislature would have made the treatments available to everyone in the state’s prisons and county jails, but the proposal faltered at the end of 2019’s legislative session. Instead, Governor Andrew Cuomo expanded opioid treatment in prisons and jails across the state: with $4 million distributed to counties and $1.2 million to state prisons under the latest state budget. Some programs will also provide Naloxone, an overdose prevention drug, to those returning home.
The reach of those programs is limited: MAT is only available at eight of New York’s 54 state prisons, and only in interventions like parole diversion, pregnant women and people serving short sentences. These pilot programs are seen by advocates as far too gradual for the full-blown epidemic inside the state’s prisons and jails.
In the meantime New York’s county jails can still punish people for bringing the potentially life-saving medication into jail with them. In January, the Ulster County Sheriff’s office announced on its Facebook page the “arrest” of someone already incarcerated after a cell search turned up Suboxone, the brand name for buprenorphine. It was the second such arrest in six months, and Ulster County has seen its opioid death rate go up 345 percent between 2010 and 2018. This is why, a few months after the Sheriff announced that arrest, county executive Pat Ryan announced federal funds would be used to provide MAT, including in Ulster County Jail—a sea change from their approach earlier in the year.
New York’s county sheriffs still have wide latitude to punish people who smuggle the treatments inside. “They operate like fiefdoms,” said Dionna King, New York Policy Manager of the Drug Policy Alliance. “The sheriffs have a lot of autonomy.”
Jails can still punish people for bringing the potentially life-saving medication into jail with them.
One formerly incarcerated person—who wanted only to be identified as “Joseph” for fear of retribution—said that bringing opioid treatment drugs inside an institution is a common precautionary measure. Some heavy opioid users don’t leave the house without tabs of Suboxone stashed in their bodies. “Motherfuckers don’t leave their house unless they have 10 Suboxone stuck in their ass. That’s how it is with us,” he said. “It’s basic medical attention they just deny us.”
ADVERTISEMENT
He described a visceral experience going through withdrawal in Albany County Correctional Facility. In April 2017, he was arrested and charged with possession of narcotics with intent to distribute. Guards laughed at him when he asked for treatment, despite a medical history showing he was a seizure risk without it.
“All I’m asking for is general medical care, man,” he said he told the guard. “These people just looked at me like I’m a junkie.” He said he was brought to a hospital for his withdrawal symptoms only through a nurse’s intervention. Earlier this year, Albany County announced it would offer all three MAT drugs in their jail.
In Rhode Island, the only state that offers all three FDA approved drugs to incarcerated people, there has been a similar trend. Dr. Josiah Rich, a Brown University professor of medicine who helped implement the state’s plan, said he had heard plenty of incidents in which people smuggled buprenorphine into the jails. Suboxone, the brand name version of buprenorphine, is distributed on small tabs that can be hidden easily. He had heard cases of people slipping tabs inside crayon wrappers or under a stamp.
But after treatment was offered in Rhode Island prisons, overdose deaths reduced 61 percent, and trading drugs in the facilities went down.
Patricia Herring, like many advocates, wants opioid addiction to be treated as a disease, not criminalized, and for more treatment to be made available in the community as well in jails. She said she finds herself wondering why her son was punished for bringing in a substance that wouldn’t have harmed anyone.
“Punishment is not the cure for the disease,” she said. “At all.”
Editor’s Note: Matthew Herring was arrested in 2016, not 2017, for a probation violation, not a parole violation. While he was eventually sent to Altona, the jail where he smuggled in suboxone was Dutchess County Jail. And while he was 24 when he died, he was 22 when that arrest happened. The story has been updated to reflect these changes.
Recent Comments